IMCR — Immunocore Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Immunocore Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	10-K	10-K	10-K
Standards:	IFRS	IFRS	USG	USG	USG
Status:	fx Final	fx Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	177	322	402	443	820
Net Total Accounts Receivable
Net Total Receivables	22.8	23.2	57.1	61.4	83.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	209	355	474	529	930
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	50.4	42.7	38.8	42.7	47.7
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	270	408	527	597	1,010
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	75.2	82.8	101	139	212
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	194	176	188	228	649
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	75.7	232	339	369	361
Total Liabilities & Shareholders' Equity	270	408	527	597	1,010
Total Common Shares Outstanding